한국어
English
日本語
中文(简体)
Semblix Tablet 20 mg (Ashimib Hydrochloride)
21.62mg
Tablet · Prescription medication
Korea Novartis Co., Ltd.
Asimib hydrochloride is an anti-cancer agent used for the treatment of chronic myeloid leukemia.
MFDS ingredient code M282794
Asimib hydrochloride is a targeted anti-cancer drug used for the treatment of chronic myeloid leukemia. It belongs to the class of tyrosine kinase inhibitors and functions by blocking growth signals in cancer cells. It is primarily included in medications to inhibit the proliferation of leukemia cells.
Asimib hydrochloride selectively blocks the active sites of certain proteins within leukemia cells. This interferes with the signal transduction that allows cancer cells to grow and divide, thereby inhibiting the proliferation of cancer cells. As a result, it slows down or halts the progression of the disease.
Approved uses differ by product. Check each product's information for its actual use.
Unlike conventional tyrosine kinase inhibitors, asimib hydrochloride acts by binding to the regulatory sites of specific proteins. This helps to overcome resistance issues, and its side effect profile also differs somewhat. Therefore, it is an important treatment option for patients who do not respond to existing therapies.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
Product approval information is based on drug information provided by the Ministry of Food and Drug Safety.
Ingredient and class descriptions are not part of MFDS data and were written separately by Cashdoc.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.
